Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2008 3
2009 1
2010 6
2011 3
2012 5
2013 1
2014 1
2015 2
2016 5
2017 7
2018 3
2019 2
2020 6
2021 15
2022 12
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Development and validation of a respiratory syncytial virus multiplex immunoassay.
Marsall P, Fandrich M, Griesbaum J, Harries M, Lange B; RESPINOW Study Consortium; Ascough S, Dayananda P, Chiu C, Remppis J, Ganzenmueller T, Renk H, Strengert M, Schneiderhan-Marra N, Dulovic A. Marsall P, et al. Among authors: schneiderhan marra n. Infection. 2024 Apr;52(2):597-609. doi: 10.1007/s15010-024-02180-6. Epub 2024 Feb 8. Infection. 2024. PMID: 38332255 Free PMC article.
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
Tandler C, Heitmann JS, Michel TM, Marconato M, Jaeger SU, Tegeler CM, Denk M, Richter M, Oezbek MT, Maringer Y, Schroeder SM, Schneiderhan-Marra N, Wiesmüller KH, Bitzer M, Ruetalo N, Schindler M, Meisner C, Fischer I, Rammensee HG, Salih HR, Walz JS. Tandler C, et al. Among authors: schneiderhan marra n. Int J Infect Dis. 2024 Feb;139:69-77. doi: 10.1016/j.ijid.2023.11.009. Epub 2023 Nov 26. Int J Infect Dis. 2024. PMID: 38016500 Free article.
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
Harries M, Jaeger VK, Rodiah I, Hassenstein MJ, Ortmann J, Dreier M, von Holt I, Brinkmann M, Dulovic A, Gornyk D, Hovardovska O, Kuczewski C, Kurosinski MA, Schlotz M, Schneiderhan-Marra N, Strengert M, Krause G, Sester M, Klein F, Petersmann A, Karch A, Lange B. Harries M, et al. Among authors: schneiderhan marra n. Int J Infect Dis. 2024 Feb;139:50-58. doi: 10.1016/j.ijid.2023.11.014. Epub 2023 Nov 24. Int J Infect Dis. 2024. PMID: 38008353 Free article.
Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia.
Fernández Villalobos NV, Marsall P, Torres Páez JC, Strömpl J, Gruber J, Lotto Batista M, Pohl D, Concha G, Frickmann H, de la Hoz Restrepo FP, Schneiderhan-Marra N, Krause G, Dulovic A, Strengert M, Kann S. Fernández Villalobos NV, et al. Among authors: schneiderhan marra n. Commun Med (Lond). 2023 Oct 20;3(1):151. doi: 10.1038/s43856-023-00376-9. Commun Med (Lond). 2023. PMID: 37864073 Free PMC article.
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P; STAR SIGN Study Investigators; Albrich WC, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: schneiderhan marra n. Aliment Pharmacol Ther. 2023 Oct;58(7):678-691. doi: 10.1111/apt.17661. Epub 2023 Aug 12. Aliment Pharmacol Ther. 2023. PMID: 37571863
86 results